+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Respiratory Diagnostics Market by Product (Assays & Reagents, Instruments & Devices, Software & Services), Test Type (Imaging Tests, Mechanical Tests, Molecular Diagnostic Tests), Indication, End-User - Forecast 2024-2030- Product Image
Global Respiratory Diagnostics Market by Product (Assays & Reagents, Instruments & Devices, Software & Services), Test Type (Imaging Tests, Mechanical Tests, Molecular Diagnostic Tests), Indication, End-User - Forecast 2024-2030- Product Image
Sale

Global Respiratory Diagnostics Market by Product (Assays & Reagents, Instruments & Devices, Software & Services), Test Type (Imaging Tests, Mechanical Tests, Molecular Diagnostic Tests), Indication, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5914461
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Respiratory Diagnostics Market size was estimated at USD 6.12 billion in 2023, USD 6.66 billion in 2024, and is expected to grow at a CAGR of 8.67% to reach USD 10.96 billion by 2030.

Respiratory diagnostics is a vital component of the healthcare industry, focusing on the identification, monitoring, and treatment of respiratory diseases, which include asthma, chronic obstructive pulmonary disease (COPD), lung tumors, tuberculosis, and pneumonia, among others. Respiratory diagnostics testing methods encompass the use of imaging tests, spirometry, peak flow tests, blood gas tests, pulmonary function tests, and multiple other diagnostic techniques. Escalation in the prevalence of such respiratory conditions due to rising air pollution levels, smoking, genetic predispositions, and occupational hazards has necessitated the use of respiratory diagnostics solutions.

However, inadequate reimbursement and insurance policies and the risk of errors associated with complex diagnostic procedures could also impede the proliferation of respiratory diagnostics. Moreover, the need for trained professionals to operate advanced diagnostic systems presents a challenge to the market's expansion. However, government initiatives aimed at enhancing health infrastructure and access to respiratory health solutions and increasing investments in research and development activities can help overcome the financial and technical limitations of respiratory diagnostics solutions. Innovations such as portable monitoring devices, advanced molecular diagnostic tests, and increased digitalization leading to the incorporation of telehealth services in respiratory care offer new areas for growth.

Regional Insights

The Americas pose a significant position in the global market for respiratory diagnostics. High incidences of respiratory diseases coupled with heightened awareness and proactive medical interventions contribute to the need for advanced respiratory diagnostics in the Americas. The availability of sophisticated healthcare infrastructure also facilitates the production of high-quality diagnostic equipment. The escalating demand for diagnostic services and the presence of rapidly developing healthcare infrastructure support the production of respiratory diagnostic devices in Asia. The prevalence of respiratory diseases and the expansion of key market players, both domestic and international,, have elevated market development in the region.

Europe's market for respiratory diagnostics is heavily influenced by the high availability of innovative respiratory diagnostic tests and the presence of well-established healthcare systems. Regulatory guidelines laid down by the European Union also pave the way for stringent quality control during the production of respiratory diagnostic devices. Middle East & Africa also observes an increasing prevalence of respiratory diseases, creating a need for consistent availability of advanced diagnosis solutions. The production of respiratory diagnostic devices is limited in the region due to a lack of local manufacturers. However, various international companies are focusing on and have expanded their foothold in this region for respiratory diagnostic device manufacturing.

Market Trends by Segment

  • Product: Need for rapid detection of pathogens driving the adoption of assays and reagents
  • Test Type: Research initiatives to advance the accuracy and specificity of molecular diagnostic tests
  • Indication: Need for advanced respiratory diagnostic technologies to attain accurate testing of chronic obstructive pulmonary disease
  • End-User: Adoption of a diverse range of diagnostic tools in hospitals and clinics for identifying and monitoring respiratory ailments

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

NYU Langone Health Enters 8-Year Partnership with Philips

Royal Philips and the NYU Langone Health developed an eight-year strategic alliance worth up to USD 115 million, dedicated to advancing patient care and fostering innovation. Central to this partnership is Philips’ provision of advanced technologies that enable NYU Langone's clinical experts to collaborate seamlessly in real-time through efficient sharing of pathology and imaging findings and patient data in pursuit of enhancing diagnostic accuracy and delivering personalized treatment strategies for all diseases, including respiratory.

Masimo Gets De Novo Approval From FDA for ORi

Masimo's innovative ORi parameter garnered De Novo clearance from the US FDA, heralding a paradigm shift in noninvasive respiratory diagnostics. This technology, integrated with Masimo's advanced Pulse CO-Oximetry system, offers continuous and comprehensive monitoring of a patient's oxygen levels, particularly in the moderate hyperoxic range when supplemental oxygen is utilized. Designed specifically to guide clinicians in optimally managing oxygen therapy for adult patients during the perioperative phase within hospital environments, ORi represents the first FDA-endorsed solution of its kind.

bioMérieux Submits Dual 510(k) and CLIA-Waiver Application to FDA for the BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel

bioMérieux announced its submission of the BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel for concurrent 510(k) clearance and CLIA waiver by the FDA, boasting existing CE marking under IVDD. This innovative multiplex PCR test, which rapidly identifies 15 common pathogens causing respiratory or sore throat infections, returns actionable results in roughly 15 minutes, a significant stride in diagnostic efficiency underscored by the urgency of the COVID-19 pandemic.

Key Company Profiles

The report delves into recent significant developments in the Respiratory Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adaltis S.r.l., Altona Diagnostics GmbH, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., bioMérieux S.A., Bioneer Corporation, CerTest Biotec S.L., Daan Gene Co., Ltd., Diatech Pharmacogenetics srl, Drägerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd., GE HealthCare Technologies, Inc., Hologic, Inc., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Masimo Corporation, Medtronic PLC, Merck KGaA, ProAxsis by NetScientific PLC, Quest Diagnostics Incorporated, Quidel Corporation, Sansure Biotech Inc., SDI Diagnostics, Inc., Seegene Inc., Siemens Healthineers AG, Somnoware by ResMed Corp., Thermo Fisher Scientific Inc., Vitalograph Ltd., and ZeptoMetrix LLC.

This research report offers invaluable insights into various crucial aspects of the Respiratory Diagnostics Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing aging population with susceptibility to chronic respiratory diseases
5.1.1.2. Growth in the approvals for respiratory disease diagnostic kits, tests, and systems
5.1.1.3. Rising preferences for remote and home care testing devices
5.1.2. Restraints
5.1.2.1. Incidences of product recall of respiratory diagnosis panels and kits with limited reimbursement policies
5.1.3. Opportunities
5.1.3.1. Technological advancements to introduce sophisticated respiratory diagnostic tools
5.1.3.2. Government initiatives and funding for respiratory diagnostic tools
5.1.4. Challenges
5.1.4.1. Risk of errors associated with complex diagnostic procedures
5.2. Market Segmentation Analysis
5.2.1. Product: Need for rapid detection of pathogens driving the adoption of assays and reagents
5.2.2. Test Type: Research initiatives to advance the accuracy and specificity of molecular diagnostic tests
5.2.3. Indication: Need for advanced respiratory diagnostic technologies to attain accurate testing of chronic obstructive pulmonary disease
5.2.4. End-User: Adoption of a diverse range of diagnostic tools in hospitals and clinics for identifying and monitoring respiratory ailments
5.3. Market Trend Analysis
5.3.1. Significant market growth potential driven by investments in healthcare infrastructure and supportive regulatory landscape in the Americas region
5.3.2. Massive need of early detection and respiratory diagnostic solutions to monitor and manage viral respiratory infections in APAC
5.3.3. Well-established respiratory diagnostics development across EMEA enabling the provision of advanced testing capabilities for government and private disease screening activities
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Respiratory Diagnostics Market, by Product
6.1. Introduction
6.2. Assays & Reagents
6.3. Instruments & Devices
6.4. Software & Services
7. Respiratory Diagnostics Market, by Test Type
7.1. Introduction
7.2. Imaging Tests
7.3. Mechanical Tests
7.4. Molecular Diagnostic Tests
7.5. OSA Diagnostic Tests
7.6. Traditional Diagnostic Tests
8. Respiratory Diagnostics Market, by Indication
8.1. Introduction
8.2. Asthma
8.3. Chronic Obstructive Pulmonary Disease
8.4. Lung Cancer
8.5. Pneumonia
8.6. Tuberculosis
9. Respiratory Diagnostics Market, by End-User
9.1. Introduction
9.2. Diagnostic Laboratories
9.3. Hospitals & Clinics
9.4. Research Institutes
10. Americas Respiratory Diagnostics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Respiratory Diagnostics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Respiratory Diagnostics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. NYU Langone Health Enters 8-Year Partnership with Philips
13.3.2. Masimo Gets De Novo Approval From FDA for ORi
13.3.3. bioMérieux Submits Dual 510(k) and CLIA-Waiver Application to FDA for the BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel
13.3.4. BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test
13.3.5. ResMed Acquires Sleep and Respiratory Diagnostics Software Maker Somnoware
13.3.6. Seegene Obtains IVDR Certification for 30 Diagnostic Assays
13.3.7. Hologic Announces FDA Clearance of Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay
13.3.8. QIAGEN Launches QIAstat-Dx in Japan with Respiratory Panel for Syndromic Testing
13.3.9. Thermo Fisher partners with ALPCO-GeneProof to Broaden Their CE-IVD Molecular Assay Portfolio
13.3.10. Molbio Diagnostics adds Truenat H3N2/H1N1 Test to Respiratory Disease Portfolio
13.3.11. Vitalograph Launches New Respiratory VitaloPFT Series
13.3.12. SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience
13.3.13. Philips and Masimo Expand Partnership To Improve Telehealth For Patients And Clinicians Around The World
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. RESPIRATORY DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. RESPIRATORY DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. RESPIRATORY DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. RESPIRATORY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. RESPIRATORY DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. RESPIRATORY DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ASSAYS & REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ASSAYS & REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & DEVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & DEVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY X-RAY, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY X-RAY, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PEAK FLOW TEST, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PEAK FLOW TEST, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULMONARY FUNCTION TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULMONARY FUNCTION TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MICROARRAYS, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OSA DIAGNOSTIC TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OSA DIAGNOSTIC TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BIOCHEMICAL TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BIOCHEMICAL TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MICROSCOPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 67. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2023 (USD MILLION)
TABLE 68. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ASTHMA, BY REGION, 2024-2030 (USD MILLION)
TABLE 69. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2023 (USD MILLION)
TABLE 70. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2024-2030 (USD MILLION)
TABLE 71. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 72. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 73. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PNEUMONIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 74. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PNEUMONIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 75. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 76. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 77. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 78. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 79. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 80. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 81. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 82. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 83. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 84. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 85. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 86. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 87. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 88. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 89. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
TABLE 90. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
TABLE 91. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
TABLE 92. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
TABLE 93. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 94. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 95. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 96. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 97. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 98. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 99. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 100. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 101. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 102. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 103. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 104. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 105. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 106. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 107. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
TABLE 108. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
TABLE 109. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
TABLE 110. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
TABLE 111. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 112. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 113. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 114. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 115. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 116. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 117. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 118. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 119. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 120. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 121. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 122. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 123. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
TABLE 124. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
TABLE 125. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
TABLE 126. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
TABLE 127. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 128. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 129. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 130. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 131. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 132. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 133. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 134. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 135. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 136. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 137. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 138. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 139. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
TABLE 140. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
TABLE 141. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
TABLE 142. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
TABLE 143. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 144. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 145. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 146. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 147. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 148. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 149. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 150. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 151. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 152. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 153. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 154. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 155. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
TABLE 156. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
TABLE 157. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
TABLE 158. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
TABLE 159. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 160. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 161. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 162. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 163. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 164. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 165. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 166. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 167. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 168. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 169. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 170. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 171. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
TABLE 172. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
TABLE 173. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
TABLE 174. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
TABLE 175. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 176. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 177. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 178. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 179. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 180. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 181. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 182. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 183. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 184. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 185. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 186. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 187. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 188. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 189. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
TABLE 190. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
TABLE 192. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 194. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 196. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 198. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 200. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 202. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 203. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 204. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 205. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 206. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 207. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
TABLE 208. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
TABLE 209. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
TABLE 210. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
TABLE 211. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 212. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 213. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 214. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 215. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 216. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 217. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 218. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 219. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 220. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 221. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 222. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 223. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
TABLE 224. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
TABLE 225. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
TABLE 226. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
TABLE 227. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 228. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 229. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 230. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 231. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 232. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 233. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 234. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 235. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 236. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 237. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 238. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 239. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
TABLE 240. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
TABLE 241. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
TABLE 242. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
TABLE 243. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 244. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 245. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 246. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 247. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 248. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 249. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 250. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 251. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 252. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 253. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 254. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 255. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
TABLE 256. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
TABLE 257. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
TABLE 258. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
TABLE 259. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 260. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 261. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 262. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 263. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 264. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 265. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 266. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 267. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 268. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 269. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 270. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 271. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
TABLE 272. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
TABLE 273. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
TABLE 274. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
TABLE 275. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 276. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 277. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 278. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 279. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 280. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 281. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 282. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 283. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 284. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 285. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 286. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 287. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
TABLE 288. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
TABLE 289. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
TABLE 290. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
TABLE 291. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 292. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 293. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 294. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 295. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 296. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 297. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 298. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 299. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 300. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 301. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 302. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 303. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
TABLE 304. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
TABLE 305. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
TABLE 306. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
TABLE 307. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 308. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 309. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
TABLE 310. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
TABLE 311. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 312. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 313. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 314. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 315. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 316. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 317. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 318. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 319. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
TABLE 320. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
TABLE 321. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)

Companies Mentioned

  • Abbott Laboratories
  • Adaltis S.r.l.
  • Altona Diagnostics GmbH
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux S.A.
  • Bioneer Corporation
  • CerTest Biotec S.L.
  • Daan Gene Co., Ltd.
  • Diatech Pharmacogenetics srl
  • Drägerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd.
  • GE HealthCare Technologies, Inc.
  • Hologic, Inc.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.
  • Masimo Corporation
  • Medtronic PLC
  • Merck KGaA
  • ProAxsis by NetScientific PLC
  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • Sansure Biotech Inc.
  • SDI Diagnostics, Inc.
  • Seegene Inc.
  • Siemens Healthineers AG
  • Somnoware by ResMed Corp.
  • Thermo Fisher Scientific Inc.
  • Vitalograph Ltd.
  • ZeptoMetrix LLC

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages195
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 6.66 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.96 Billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Respiratory Diagnostics Market Report by Product and Service Type, Test Type, Disease, End-User, and Region 2024-2032 - Product Image

Respiratory Diagnostics Market Report by Product and Service Type, Test Type, Disease, End-User, and Region 2024-2032

  • Report
  • 145 Pages
  • Global
From
Respiratory Diagnostics - Global Strategic Business Report - Product Image

Respiratory Diagnostics - Global Strategic Business Report

  • Report
  • 174 Pages
  • Global
From
Global Respiratory Diagnostics Market: Focus on Disease Indication, Type, Test Type, End User, and Over 16 Countries' Data - Analysis and Forecast, 2024-2033 - Product Image

Global Respiratory Diagnostics Market: Focus on Disease Indication, Type, Test Type, End User, and Over 16 Countries' Data - Analysis and Forecast, 2024-2033

  • Report
  • 159 Pages
  • Global
From
Respiratory Diagnostic Devices Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Respiratory Diagnostic Devices Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 103 Pages
  • Global
From
Global Respiratory Infection Diagnostics Market by Test (Antigen Detection Assays, Direct Fluorescent Antibody Tests, Imaging Tests), Disease (Asthma, Chronic Obstructive Pulmonary Disease, Coronavirus Infections), End-User - Forecast 2024-2030 - Product Image

Global Respiratory Infection Diagnostics Market by Test (Antigen Detection Assays, Direct Fluorescent Antibody Tests, Imaging Tests), Disease (Asthma, Chronic Obstructive Pulmonary Disease, Coronavirus Infections), End-User - Forecast 2024-2030

  • Report
  • 186 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.